To explore the hypothesis that susceptibility to cerebral malaria is influenced by genetic variation in endothelial nitric oxide synthase (eNOS), we genotyped three commonly defined polymorphic loci of eNOS, Glu 298 3Asp, intron 4 variable number of tandem repeat region, and T-7863C, in 244 patients (mean age, 36.2 years) with mild malaria and 194 patients (mean age, 35.6 years) with severe malaria belonging to same ethnic group in Orissa, an eastern Indian state. We found that there was an association of the Glu 298 3Asp substitution (P ؍ 0.0037; odds ratio, 1.95; 95% confidence interval, 1.2 to 3.0) and a single unique haplotype defined by "C-b-Asp" (P corrected ؍ 0.0024) for protection against cerebral malaria. Further, the median plasma level of nitrite-nitrate was found to be increased in individuals with the Glu 298 3Asp substitution and was significantly higher in the mild malaria group (P < 0.0001), but the increase was not significant in the severe malaria group (P ؍ 0.0528). These findings suggest that the Glu 298 3Asp substitution and the "C-b-Asp" haplotype may enhance eNOS expression and NO production, which leads to protection against cerebral malaria. These findings may increase our understanding of the pathogenesis of malaria.Malaria parasites are major human pathogens that annually are associated with 300 million to 500 million clinical cases worldwide and 1 million to 3 million deaths (2). Despite high infection rates, only 1% to 2% of malaria patients develop life-threatening complications, such as cerebral malaria and profound anemia, so natural selection has likely operated, to a large extent, on severity (11). This has prompted the search for factors involved in natural resistance to severe malaria. The severity of malaria depends largely upon the capacity of Plasmodium falciparum-infected erythrocytes (RBCs) to adhere to the endothelia of microvessels (cytoadherence) and to form rosettes with uninfected RBCs (14). This results in a high parasite burden and severe proinflammatory responses in localized areas, leading to endothelial damage and organ dysfunction (7). Further, upregulation of endothelial cell adhesion molecules in response to tumor necrosis factor alpha potentially augments the cytoadherence (22). However, in recent studies, increased NO production has been shown to be beneficial because of its antiparasitic and antidisease effect, although this is controversial, (1). This effect is due to inhibition of the cytoadherence process through downregulation of the expression of ICAM1, VCAM1, and E-selectin, which are involved in cytoadherence and microvascular sequestration of parasitized RBCs (18) and decreased production of tumor necrosis factor by macrophages (9). NO is produced during the enzymatic conversion of L-arginine to L-citrulline by three isoforms of nitric oxide synthase (NOS), namely inducible NOS, endothelial NOS (eNOS), and neuronal NOS (19). The eNOSderived NO mediates vasodilation, inhibits platelet aggregation and endothelial cell activation, and modulates ...